Collect superior samples for your clinical trials

All genetic analysis and testing starts with the collection of DNA samples. Oragene•DNA is ideal for any clinical application that requires DNA to derive a result. Pharmaceutical companies will improve recruitment and decrease costs using a completely non-invasive, reliable and easy-to-use sample collection method.

Oragene•DNA offers an all-in-one system for collection, stabilization, transportation and purification of DNA from saliva.

• Collect high quality and high quantity DNA
• Improve recruitment and speed time to market with easy-to-use and painless sample collection
• Decrease cost and complexity of sample transport, management and storage with long-term room temperature stability of samples
• Improve processing efficiency with seamless integration with automated platforms

Features and Benefits

• Painless, non-invasive collection of high quality, high quantity DNA
• Improve recruitment while eliminating phlebotomy costs and inconvenience
• Ideal for use with all donors, including young children or patients that will not comply with blood collections
• Reliable for use in any collection environment: in the clinic, at the physician's office or even at home
• Compact and robust for transport via the standard postal system
• Increase efficiency, minimize sample handling and reduce handling errors with a compatible format for high-throughput processing
• Proven to perform as well as blood on downstream applications from PCR based applications to microarrays
• FDA registered, CE & IVD certified
• Customized packaging and options are available

"The collection protocol is very convenient, the extraction is very quick and simple, and the yield is great. Our downstream applications include PCR, restriction enzyme digestion and sequencing.

We have collected numerous family members who were not willing to go for a blood draw, as well as children, elderly patients and overseas relatives. The ease of shipping and self-collection are remarkable. Our lab is very impressed with this timely product."

Ruth McPherson, MD, PhD and Nihan Kavaslar, PhD
Lipoproteins and Atherosclerosis Research Group, University of Ottawa Heart Institute